history of glp-1 agonists Market Report 2025-2033, By Product, Molecule, and Geo Evolution of incretin (GLP-1 and

Compound Name: Retatrutide (Triple Agonist Analog)

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

This product is not intended to diagnose, treat, cure, or prevent any disease

GLP-1 receptor agonists (GLP-1 RAs) with exenatide b.i.d

The aim of this narrative review is to critically assess the renoprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in managing albuminuria among patients with type 2 diabetes mellitus within the framework of personalized ...